These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30950571)

  • 1. Challenges and Opportunities in Cancer Metabolomics.
    Kumar A; Misra BB
    Proteomics; 2019 Nov; 19(21-22):e1900042. PubMed ID: 30950571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
    Cui L; Lu H; Lee YH
    Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometry.
    Gao Y; Chen Y; Yue X; He J; Zhang R; Xu J; Zhou Z; Wang Z; Zhang R; Abliz Z
    Anal Chim Acta; 2018 Dec; 1037():369-379. PubMed ID: 30292313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges, progress and promises of metabolite annotation for LC-MS-based metabolomics.
    Chaleckis R; Meister I; Zhang P; Wheelock CE
    Curr Opin Biotechnol; 2019 Feb; 55():44-50. PubMed ID: 30138778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.
    Coene KLM; Kluijtmans LAJ; van der Heeft E; Engelke UFH; de Boer S; Hoegen B; Kwast HJT; van de Vorst M; Huigen MCDG; Keularts IMLW; Schreuder MF; van Karnebeek CDM; Wortmann SB; de Vries MC; Janssen MCH; Gilissen C; Engel J; Wevers RA
    J Inherit Metab Dis; 2018 May; 41(3):337-353. PubMed ID: 29453510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics: a revolution for novel cancer marker identification.
    Bu Q; Huang Y; Yan G; Cen X; Zhao YL
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Spectrometry-Based Metabolomics.
    Kim YM; Heyman HM
    Methods Mol Biol; 2018; 1775():107-118. PubMed ID: 29876813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted Metabolomics Strategies-Challenges and Emerging Directions.
    Schrimpe-Rutledge AC; Codreanu SG; Sherrod SD; McLean JA
    J Am Soc Mass Spectrom; 2016 Dec; 27(12):1897-1905. PubMed ID: 27624161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Metabolomics in Lung Research.
    Reisdorph NA; Cruickshank-Quinn C; Nkrumah-Elie Y; Reisdorph R
    Methods Mol Biol; 2018; 1809():263-288. PubMed ID: 29987794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges.
    Burton C; Ma Y
    Curr Med Chem; 2019; 26(1):5-28. PubMed ID: 28914192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in metabolite identification.
    Wishart DS
    Bioanalysis; 2011 Aug; 3(15):1769-82. PubMed ID: 21827274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics for mitochondrial and cancer studies.
    Nagrath D; Caneba C; Karedath T; Bellance N
    Biochim Biophys Acta; 2011 Jun; 1807(6):650-63. PubMed ID: 21420931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Throughput Solid-Phase Microextraction-Liquid Chromatography-Mass Spectrometry for Microbial Untargeted Metabolomics.
    Mousavi F; Bojko B; Pawliszyn J
    Methods Mol Biol; 2019; 1859():133-152. PubMed ID: 30421227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.
    Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ
    Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncometabolomics in cancer research.
    Gupta S; Chawla K
    Expert Rev Proteomics; 2013 Aug; 10(4):325-36. PubMed ID: 23992416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated, untargeted metabolomics analysis of cutaneous T-cell lymphoma reveals metabolic shifts in plasma and tumor adjacent skins of xenograft mice.
    Le Y; Shen X; Kang H; Wang Q; Li K; Zheng J; Yu Y
    J Mass Spectrom; 2018 Feb; 53(2):172-182. PubMed ID: 29160924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.
    Long NP; Yoon SJ; Anh NH; Nghi TD; Lim DK; Hong YJ; Hong SS; Kwon SW
    Metabolomics; 2018 Aug; 14(8):109. PubMed ID: 30830397
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.